Peter Maag - Aug 20, 2024 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Director
Signature
/s/ Peter Maag
Stock symbol
CDNA
Transactions as of
Aug 20, 2024
Transactions value $
-$961,897
Form type
4
Date filed
8/22/2024, 04:43 PM
Previous filing
Jul 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $213K +26.7K +7.88% $7.96 366K Aug 20, 2024 Direct
transaction CDNA Common Stock Sale -$294K -8.84K -2.42% $33.23 357K Aug 20, 2024 Direct
transaction CDNA Common Stock Sale -$462K -13.9K -3.89% $33.25 343K Aug 20, 2024 Direct F1
transaction CDNA Common Stock Sale -$419K -12.8K -3.74% $32.67 330K Aug 20, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -26.7K -91.67% $0.00 2.43K Aug 20, 2024 Common Stock 26.7K $7.96 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.75, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.345 to $33.000, inclusive.
F3 This option was originally granted on June 16, 2023 and, as of June 16, 2024, was fully vested.